Close

Cytori Therapeutics (CYTX) Issues Encouraging Update on Cell Therapy in ACL Clinical

November 21, 2014 8:01 AM EST Send to a Friend
Cytori Therapeutics (Nasdaq: CYTX) reported positive results from a clinical study of Cytori Cell Therapy in anterior cruciate ligament (ACL) ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login